New Uncertainty into Approval Process for Covid Boosters
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible implications for Pfizer and Moderna.
Comment
Show comments
Hide Comments
